Frieda Klein

Frieda Klein is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as Director CMC at NeoTX Therapeutics LTD since June 2021. Previously, Frieda held the position of R&D Director at SciVac Ltd. from August 2013 to June 2021 and worked at Teva Pharmaceuticals from December 2004 to May 2012 as a Section Manager in the QC biogeneric lab and as a team leader and manager of Biological Methods Development. Frieda Klein earned a Ph.D. in Biology from Bar-Ilan University, completing the program in 2004.